- Home
- GPOR vs CORT Comparison
GPOR vs CORT Comparison
Compare GPOR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GPOR | CORT |
|---|---|---|
| Founded | 1997 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.7B |
| IPO Year | 1998 | 2001 |
Fundamental Metrics
Financial Performance| Metric | GPOR | CORT |
|---|---|---|
| Price | $168.60 | $75.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $233.33 | $96.50 |
| AVG Volume (30 Days) | 249.9K | ★ 1.0M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 245.92 | N/A |
| EPS | ★ 8.87 | N/A |
| Revenue | ★ $1,422,583,000.00 | $761,407,000.00 |
| Revenue This Year | $18.35 | $26.08 |
| Revenue Next Year | $6.04 | $26.98 |
| P/E Ratio | $18.95 | ★ N/A |
| Revenue Growth | ★ 48.47 | 12.79 |
| 52 Week Low | $160.95 | $28.66 |
| 52 Week High | $225.78 | $91.00 |
Technical Indicators
Market Signals| Indicator | GPOR | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 32.52 | 81.25 |
| Support Level | $166.91 | $73.79 |
| Resistance Level | $178.25 | $79.89 |
| Average True Range (ATR) | 4.52 | 2.68 |
| MACD | -0.19 | 0.77 |
| Stochastic Oscillator | 10.86 | 97.39 |
Price Performance
Historical ComparisonAbout GPOR Gulfport Energy Corporation
Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets located in the Appalachia and Anadarko basins in the United States. The principal properties of the company are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.